Von Baer Wolff is focused on the fabrication of human hepatocytes with one primary goal: To become the premier supplier of iPS-derived human hepatocytes to science and industry...
Our technology is complex but its benefits are easy to measure. Significant cost savings, improved drug safety and effectiveness, and hope for those affected with liver disease. An abundant supply of human hepatocytes empowers researchers to explore new ideas that can positively impact patient outcomes.